Abstract
A severe systemic inflammatory response is usually seen after burn injury. IL-
A severe systemic inflammatory response is usually seen after burn injury. IL-
M Ueyama, I Maruyama, M Osame, and Y Sawada, “Marked increase in plasma interleukin-6 in burn patients,” The Journal of Laboratory and Clinical Medicine, vol. 120, no. 5, pp. 693–698, 1992.
View at: Google ScholarS Endo, K Inada, Y Yamada et al., “Plasma tumour necrosis factor- (TNF-) levels in patients with burns,” Burns, vol. 19, no. 2, pp. 124–127, 1993.
View at: Google ScholarA L Dugan, W B Malarkey, S Schwemberger, E C Jauch, C K Ogle, and N D Horseman, “Serum levels of prolactin, growth hormone, and cortisol in burn patients: correlations with severity of burn, serum cytokine levels, and fatality,” Journal of Burn Care & Rehabilitation, vol. 25, no. 3, pp. 306–313, 2004.
View at: Google ScholarJ P de Bandt, S Chollet-Martin, A Hernvann et al., “Cytokine response to burn injury: relationship with protein metabolism,” The Journal of Trauma, vol. 36, no. 5, pp. 624–628, 1994.
View at: Google ScholarF L Yeh, W L Lin, and H D Shen, “Changes in circulating levels of an anti-inflammatory cytokine interleukin 10 in burned patients,” Burns, vol. 26, no. 5, pp. 454–459, 2000.
View at: Google ScholarF L Yeh, W L Lin, H D Shen, and R H Fang, “Changes in circulating levels of interleukin 6 in burned patients,” Burns, vol. 25, no. 2, pp. 131–136, 1999.
View at: Google ScholarF L Yeh, W L Lin, H D Shen, and R H Fang, “Changes in serum tumour necrosis factor- in burned patients,” Burns, vol. 23, no. 1, pp. 6–10, 1997.
View at: Google ScholarD Takeuchi, H Yoshidome, A Kato et al., “Interleukin 18 causes hepatic ischemia/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice,” Hepatology, vol. 39, no. 3, pp. 699–710, 2004.
View at: Google ScholarF N Lauw, J Branger, S Florquin et al., “IL-18 improves the early antimicrobial host response to pneumococcal pneumonia,” The Journal of Immunology, vol. 168, no. 1, pp. 372–378, 2002.
View at: Google Scholar“American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis,” Critical Care Medicine, vol. 20, no. 6, pp. 864–874, 1992.
View at: Google ScholarK Nakanishi, T Yoshimoto, H Tsutsui, and H Okamura, “Interleukin-18 regulates both Th1 and Th2 responses,” Annual Review of Immunology, vol. 19, pp. 423–474, 2001.
View at: Google ScholarK Nakanishi, T Yoshimoto, H Tsutsui, and H Okamura, “Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu,” Cytokine & Growth Factor Reviews, vol. 12, no. 1, pp. 53–72, 2001.
View at: Google ScholarH Okamura, H Tsutsi, T Komatsu et al., “Cloning of a new cytokine that induces IFN- production by T cells,” Nature, vol. 378, no. 6552, pp. 88–91, 1995.
View at: Google ScholarS Ushio, M Namba, T Okura et al., “Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein,” The Journal of Immunology, vol. 156, no. 11, pp. 4274–4279, 1996.
View at: Google ScholarA Billiau, “Interferon-gamma: biology and role in pathogenesis,” Advances in Immunology, vol. 62, pp. 61–130, 1996.
View at: Google ScholarW-D Döcke, F Randow, U Syrbe et al., “Monocyte deactivation in septic patients: restoration by IFN- treatment,” Nature Medicine, vol. 3, no. 6, pp. 678–681, 1997.
View at: Google ScholarB Conti, J W Jahng, C Tinti, J H Son, and T H Joh, “Induction of interferon- inducing factor in the adrenal cortex,” The Journal of Biological Chemistry, vol. 272, no. 4, pp. 2035–2037, 1997.
View at: Google ScholarT Suda, T Takahashi, P Golstein, and S Nagata, “Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family,” Cell, vol. 75, no. 6, pp. 1169–1178, 1993.
View at: Google ScholarA McKay, M Komai-Koma, K J MacLeod et al., “Interleukin-18 levels in induced sputum are reduced in asthmatic and normal smokers,” Clinical & Experimental Allergy, vol. 34, no. 6, pp. 904–910, 2004.
View at: Google ScholarF Giugliano, K Esposito, C Di Palo et al., “Erectile dysfunction associates with endothelial dysfunction and raised proinflammatory cytokine levels in obese men,” Journal of Endocrinological Investigation, vol. 27, no. 7, pp. 665–669, 2004.
View at: Google ScholarH M Wang, W F Cao, Y Z Peng, G X Xiao, and X Y Yang, “Changes in plasma levels of LPS, TNF- and IL-6 in burn patients with severe infection treated with Imipenem or Cefoperazone,” Zhonghua Shao Shang Za Zhi, vol. 20, no. 2, pp. 95–97, 2004 (Chinese).
View at: Google ScholarM Kinoshita, S Seki, S Ono, N Shinomiya, and H Hiraide, “Paradoxical effect of IL-18 therapy on the severe and mild Escherichia coli infections in burn-injured mice,” Annals of Surgery, vol. 240, no. 2, pp. 313–320, 2004.
View at: Google ScholarM G Netea, G Fantuzzi, B J Kullberg et al., “Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia,” The Journal of Immunology, vol. 164, no. 5, pp. 2644–2649, 2000.
View at: Google ScholarB Liu, I Mori, M J Hossain, L Dong, K Takeda, and Y Kimura, “Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity,” Journal of General Virology, vol. 85, no. pt 2, pp. 423–428, 2004.
View at: Google ScholarK Kohno, J Kataoka, T Ohtsuki et al., “IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12,” The Journal of Immunology, vol. 158, no. 4, pp. 1541–1550, 1997.
View at: Google Scholar